DK115189A - Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf - Google Patents

Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf

Info

Publication number
DK115189A
DK115189A DK115189A DK115189A DK115189A DK 115189 A DK115189 A DK 115189A DK 115189 A DK115189 A DK 115189A DK 115189 A DK115189 A DK 115189A DK 115189 A DK115189 A DK 115189A
Authority
DK
Denmark
Prior art keywords
sulfated
antigen
fragments
procedures
preparing
Prior art date
Application number
DK115189A
Other languages
English (en)
Other versions
DK115189D0 (da
Inventor
Boeckel Constant Adriaan A Van
Dedem Gijisbert Willem Kar Van
Neeltje Anna Kraayeveld
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK115189D0 publication Critical patent/DK115189D0/da
Publication of DK115189A publication Critical patent/DK115189A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
DK115189A 1988-03-10 1989-03-09 Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf DK115189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8800597 1988-03-10

Publications (2)

Publication Number Publication Date
DK115189D0 DK115189D0 (da) 1989-03-09
DK115189A true DK115189A (da) 1989-09-11

Family

ID=19851917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115189A DK115189A (da) 1988-03-10 1989-03-09 Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf

Country Status (10)

Country Link
US (1) US5071969A (da)
EP (1) EP0333243A3 (da)
JP (1) JPH01282201A (da)
KR (1) KR890014128A (da)
AU (1) AU609586B2 (da)
DK (1) DK115189A (da)
FI (1) FI891131A (da)
NZ (1) NZ228271A (da)
PT (1) PT89958A (da)
ZA (1) ZA891502B (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4776743A (en) * 1986-10-13 1988-10-11 Nichiden Machinery, Limited Lead-frame separating apparatus
US5535998A (en) * 1993-04-16 1996-07-16 Kolbus Gmbh & Co. Kg Sheet separation method and apparatus

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0454220T3 (da) * 1990-04-23 1993-11-22 Sanofi Elf Carbohydratderivater omfattende en trisaccharidenhed
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
GB2254083A (en) * 1991-03-28 1992-09-30 Italfarmaco Spa Anticoagulants from e.coli saccharide
FR2684385B1 (fr) * 1991-11-28 1997-08-01 Sanofi Elf Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2687686B1 (fr) * 1992-02-26 1994-05-27 Sanofi Elf Enzyme destinee a la fragmentation du n-acetylheparosane, obtention des preparations contenant cette enzyme et procedes de fragmentation utilisant cette enzyme.
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
IT1289613B1 (it) * 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
ITMI991465A1 (it) * 1999-07-02 2001-01-02 Inalco Spa Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli
ES2423888T3 (es) 2001-09-07 2013-09-25 Alchemia Limited Pentasacáridos de heparina sintéticos
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
MXPA04012714A (es) * 2002-06-18 2005-08-15 Glycores 2000 Srl Derivados epimerizados del polisacarido k5 con un grado muy alto de sulfatacion.
JP2006291102A (ja) * 2005-04-13 2006-10-26 National Institute Of Advanced Industrial & Technology 精製オリゴ糖画分
EP1872791A1 (en) * 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
FR2949114B1 (fr) * 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0066908B1 (en) * 1981-05-21 1985-08-28 Akzo N.V. New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
GB2128617A (en) * 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
EP0158291A3 (en) * 1984-04-10 1988-07-27 Takeda Chemical Industries, Ltd. A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4776743A (en) * 1986-10-13 1988-10-11 Nichiden Machinery, Limited Lead-frame separating apparatus
US5535998A (en) * 1993-04-16 1996-07-16 Kolbus Gmbh & Co. Kg Sheet separation method and apparatus

Also Published As

Publication number Publication date
US5071969A (en) 1991-12-10
EP0333243A2 (en) 1989-09-20
EP0333243A3 (en) 1989-09-27
FI891131A (fi) 1989-09-11
FI891131A0 (fi) 1989-03-09
KR890014128A (ko) 1989-10-21
DK115189D0 (da) 1989-03-09
NZ228271A (en) 1991-05-28
AU3090189A (en) 1989-09-21
JPH01282201A (ja) 1989-11-14
AU609586B2 (en) 1991-05-02
PT89958A (pt) 1989-11-10
ZA891502B (en) 1989-11-29

Similar Documents

Publication Publication Date Title
DK115189D0 (da) Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf
DK61189D0 (da) Stabilt, vaeskeformigt vaskemiddel og toejbloedgoeringsmiddel samt fremgangsmaade til fremstilling heraf
DK531887D0 (da) Mutagenese- og screeningsfremgangsmaade samt produkt
NO901349L (no) Fremgangsmaate for maaling eller testing.
NO882917D0 (no) Fusjonsproteiner og partikler.
NO881853D0 (no) Innretning for gradering av kjoett eller fisk.
NO894185D0 (no) Fremgangsmaate for fremstilling av 1-buten- og/eller heksener.
DK477685D0 (da) Peptidsubstituerede heterocycliske forbindelser og anvendelse deraf som immunostimulerende eller antiinfektive forbindelser samt farmaceutiske praeparater
DK469189A (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO892269L (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
DK614589D0 (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
IT1230254B (it) Procedimento e dispositivo per la realizzazione di pannelli.
ATA160189A (de) Zubereitungen zur verwendung in der bauindustrie
IT8820276A0 (it) Procedimento per la sintesi di ossalil_ ed ossamil_idrazidi.
NO890816L (no) De-emulgeringsblandinger og fremgangsmaater ved fremstilling og anvendelse derav.
DK359189D0 (da) Azolderivater, fremgangsmaade til fremstilling heraf samt farmaceutisk eller veterinaert middel omfattende et saadant azolderivat
DK304789D0 (da) Saccharid og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende saccharidet
NO901758L (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
NO860119L (no) Fremgangsmaate for stabilisering av fraktureringsvaesker og middel for utfoerelse av denne.
IT1216742B (it) Dispositivo e procedimento per la realizzazione estemporanea di testdiagnostici quantitativi sul sangue intero.
NO166291C (no) Avvanningsapparat for slamliknende eller slaminneholdendemateriale.
IT8541587A0 (it) Procedimento e mezzi per lapreparazione di ananas in dischi e/o segmenti.
IT1230098B (it) Dispositivo e procedimento per la realizzazione di opere sotterranee.
NO904027D0 (no) Aluminapartikler og fremgangsmaate for fremstilling av disse.
IT8782625A0 (it) Dispositivo per la realizzazione di doposci e/o stivaletti e doposci e/o stivaletti ottenuti con detto procedimento.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment